ABSTRACT
Measuring a patient’s impairment and disability must, by necessity, differ from evaluating the impact of therapies on impairment and disability. In the former, we are focused on the individual in order to alleviate suffering, prevent problems and impact on the course of disease. In the latter, we are interested in assessing evidence in favor of a therapy and predicting whether that therapy is beneficial to patients in general.
